ECOG-ACRIN (E4805) Randomized Phase II Study to Determine...

  • Main
  • 2017 / 4
  • ECOG-ACRIN (E4805) Randomized Phase II Study to Determine...
Clinical Genitourinary Cancer 2017 / 4

ECOG-ACRIN (E4805) Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients with Metastatic Renal Cell Carcinoma

Pili, Roberto, Jegede, Opeyemi, Carducci, Michael A., Manola, Judith, Groteluschen, David L., Appleman, Leonard L., Liu, Glenn, Shanks, James C., Dakhil, Shaker R., Dutcher, Janice, DiPaola, Robert S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Genitourinary Cancer
DOI:
10.1016/j.clgc.2017.04.023
Date:
April, 2017
File:
PDF, 1.19 MB
english, 2017
Conversion to is in progress
Conversion to is failed